Daniele Armenia

Associate Professor

Saint Camillus International University of Health Sciences

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniele Armenia is an Associate Professor at Saint Camillus International University of Health Sciences in Italy. His research primarily focuses on HIV-1 genotypic resistance testing, virological efficacy in treatment regimens, and the impact of viral mutations in diverse populations. Recent publications include studies on CMV seroprevalence in heart disease patients and the effectiveness of integrase genotyping across different HIV-1 clades.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

VALENTINA SVICHER

University of Rome Tor Vergata

ITALY

View details

maria santoro

Assistant professor

University of Rome Tor Vergata

ITALY

View details

CHRISTINE KATLAMA

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniele Armenia

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases

Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V – The LAMRES Study

Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients.

Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV

Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers.

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.

Collaborators (3)

VALENTINA SVICHER

maria santoro

CHRISTINE KATLAMA

Make your next move.